Finance

Beta
Lists
VIR:NASDAQ
Vir Biotechnology Inc
9,40 $
-2,19%
(-0,21) 1D
9,41 $
+0,11% (+0,010)
After hours
Closed: 16 հլս, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VIR...
Open
9,54 $
High
9,70 $
Low
9,12 $
Mkt. cap
1,59 մլրդ
Avg. vol.
2,11 մլն
Volume
1,96 մլն
52-wk high
11,50 $
52-wk low
4,16 $
EPS
-3,14 $
Beta
1,62
Shares outstanding
168,65 մլն
No. of employees
367
Open
9,54 $
High
9,70 $
Low
9,12 $
Mkt. cap
1,59 մլրդ
Avg. vol.
2,11 մլն
Volume
1,96 մլն
52-wk high
11,50 $
52-wk low
4,16 $
EPS
-3,14 $
Beta
1,62
Shares outstanding
168,65 մլն
No. of employees
367
News stories
From sources across the web
About Vir Biotechnology Inc
CEOMarianne De Backer
Employees367
Founded07 ապր, 2016 թ.
HeadquartersՍան Ֆրանցիսկո, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitevir.bio
Analyst ratings
Based on 9 analysts giving stock ratings to VIR in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for VIR in the last 3 months.
Highest
Current 9,40 $
30,00 $ (+219,15%)
Average
21,43 $ (+127,98%)
Lowest
16,00 $ (+70,21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Ulz
Morgan Stanley
Buy
Reiterated
27,00 $
+187,2%
06/11/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
20,00 $
+112,8%
06/03/2026
Etzer Darout
Barclays
Buy
Maintained
30,00 $
+219,1%
06/01/2026
Alec Stranahan
Bank of America Securities
Buy
Maintained
16,00 $
+70,2%
05/29/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
-
-
05/27/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
18,00 $
+91,5%
05/07/2026
Joseph Stringer
Needham
Buy
Maintained
18,00 $
+91,5%
05/07/2026
Paul Choi
Goldman Sachs
Buy
Maintained
21,00 $
+123,4%
05/06/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
05/07/2026
Sean McCutcheon
Raymond James
Buy
Maintained
19,00 $
+102,1%
02/24/2026
Last report
06 մյս, 2026 թ.
Fiscal period
Q1 2026
EPS / Est. (USD)
-0,85 $ / 0,48 $
-276,62%miss
Revenue / Est. (USD)
-29,00 հզր / 109,28 մլն
-100,03%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
1,21 մլն
240,00 հզր
64,07 մլն
-29,00 հզր
Cost of goods sold
97,52 մլն
151,45 մլն
88,46 մլն
109,81 մլն
Cost of revenue
97,52 մլն
151,45 մլն
88,46 մլն
109,81 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,28 մլն
22,23 մլն
23,62 մլն
23,34 մլն
Operating expense
22,28 մլն
22,23 մլն
23,62 մլն
23,34 մլն
Total operating expenses
119,80 մլն
173,68 մլն
112,07 մլն
133,15 մլն
Operating income
-118,59 մլն
-173,44 մլն
-48,00 մլն
-133,18 մլն
Other non operating income
226,00 հզր
-228,00 հզր
-335,00 հզր
-254,00 հզր
EBT including unusual items
-110,79 մլն
-162,97 մլն
-43,06 մլն
-125,52 մլն
EBT excluding unusual items
-107,58 մլն
-164,31 մլն
-40,53 մլն
-126,24 մլն
Income tax expense
170,00 հզր
168,00 հզր
-137,00 հզր
170,00 հզր
Effective tax rate
-0,15%
-0,10%
0,32%
-0,14%
Other operating expenses
-
-
-
-
Net income
-110,96 մլն
-163,14 մլն
-42,92 մլն
-125,70 մլն
Net profit margin
-9 139,87%
-67 975,42%
-66,99%
433 431,03%
Earnings per share
-0,80
-1,17
-0,31
-0,85
Interest and investment income
10,78 մլն
9,36 մլն
7,80 մլն
7,19 մլն
Interest expense
-
-
-
-
Net interest expenses
10,78 մլն
9,36 մլն
7,80 մլն
7,19 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-115,67 մլն
-170,44 մլն
-45,10 մլն
-130,37 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more